Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,405,840
-$41,131,633 QoQ
Shares Held
416,487
-20.4% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#85
of 663 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 1%
None 1%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Sep 30, 2024CallValue
$401,500
CallShares
5,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. INSM ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
This page
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in INSM
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,405,840 | 416,487 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $85,537,473 | 523,101 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $88,205,382 | 506,811 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $195,181,214 | 1,355,331 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $43,053,890 | 427,801 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $18,711,036 | 245,262 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $12,708,329 | 184,072 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,631,828 | 200,436 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $401,500 | 5,500 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $368,500 | 5,500 | Call | Sole | 2024-11-06 | |
| 2024-06-30 | $12,668,092 | 189,076 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $1,015,960 | 37,448 | Shares | Defined | 2024-11-05 | |
| 2024-03-31 | $149,215 | 5,500 | Call | Sole | 2024-11-05 | |
| 2023-12-31 | $2,267,072 | 73,155 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,737,779 | 68,823 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,048,921 | 49,712 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $950,178 | 55,729 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,083,952 | 54,252 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $613,048 | 28,461 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $540,248 | 27,396 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $845,506 | 35,979 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,338,709 | 49,145 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $994,274 | 36,103 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,624,863 | 92,230 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,451,810 | 160,065 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $505,274 | 15,178 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $216,044 | 6,722 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $24,675 | 896 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $19,010 | 1,186 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||